News

Recent news posts

March 8, 2024
Labshares Collaborates with Mispro and Charles River Accelerator and Development Lab (CRADL) to Create New Vivarium Partnerships
Labshares Collaborates with Mispro and Charles River Accelerator and Development Lab (CRADL) to Create New Vivarium Partnerships
April 28, 2020
Labshares Newton Awards Free Project-Based Lab Space to Three Innovative Diagnostics Companies Conducting COVID-19 Research​
Labshares Newton Awards Free Project-Based Lab Space to Three Innovative Diagnostics Companies Conducting COVID-19 Research​

All news posts

August 19, 2019

Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at up to $202 million with an undisclosed, large commercial-stage biopharmaceutical company ...
Member News
June 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Member News
May 9, 2019

Labshares Newton Selects Savran Technologies as Winner of First Launch@Labshares Competition Valued at $50K

Second Launch@Shares Competition Announced in Collaboration with MTTC/MALSI Conference and MassBio’s MassCONNECT Program
Press Releases
Fill this out and schedule your call
Select a Date & Time
Oops! Something went wrong while submitting the form.
Fill this out and schedule your visit
Select a Date & Time
Oops! Something went wrong while submitting the form.